BiotechTube
Home/ImmunoScape/Andrian Bot, MD/PhD
AB

Andrian Bot, MD/PhD

Chief Scientific Officer

ImmunoScape

Therapeutic Areas

Oncology

ImmunoScape Pipeline

DrugIndicationPhase
IS-001WT1‑positive solid tumorsPhase 1
CUE-102WT1‑positive tumors (booster)Phase 1

Leadership Team at ImmunoScape

MF
Michael Fehlings, PhD
Chief Executive Officer
RC
Romi Chandiramani, CA
Chief Financial Officer
AN
Alessandra Nardin, DVM
Vice President, Strategy
TK
Tan Kar Wai, PhD
Vice President, Discovery and Preclinical Sciences
View full ImmunoScape profile